Filter Results
:
(4,907)
Show Results For
-
All HBS Web
(4,907)
- People (16)
- News (1,838)
- Research (2,287)
- Events (2)
- Multimedia (205)
- Faculty Publications (1,811)
Show Results For
-
All HBS Web
(4,907)
- People (16)
- News (1,838)
- Research (2,287)
- Events (2)
- Multimedia (205)
- Faculty Publications (1,811)
- 01 Feb 1997
- News
Herzlinger on Health Care: Revolution in Evolution
use expensive technology, which many people cite as the reason for high U.S. health-care costs? Actually,the opposite is true: advances in medical technology have made health care cheaper and better - and...
View Details
- 28 Nov 2016
- News
What’s good for employee health is good for the company
- February 1999 (Revised March 2000)
- Case
Beth Israel Deaconess Medical Center: Coordinating Patient Care
External cost pressures are motivating the adoption of case management (CM) at Beth Israel Deaconess Medical Center (BIDMC), but several of the organization's key professional groups are working against it. President and CEO David Dolins must decide whether CM is...
View Details
Keywords:
Organizational Change and Adaptation;
Service Operations;
Organizational Culture;
Health Care and Treatment;
Health Industry;
Boston
Gittell, Jody H., Kristin Shu, and Julian Wimbush. "Beth Israel Deaconess Medical Center: Coordinating Patient Care." Harvard Business School Case 899-213, February 1999. (Revised March 2000.)
- Web
Organize Care Around Medical Conditions - Institute For Strategy And Competitiveness
HBS ISC Health Care Health Care Value-Based Health Care View Details
- 14 Dec 2013
- News
IT Start-Up Eases Health Plan Hiccups
- 01 Dec 2007
- News
Where Are the Innovators in Health Care?
billion of the excessive costs of U.S. health care while all too many quality measures have worsened. Patients learn — sometimes the hard way — to bring along an assertive, intelligent loved one to protect...
View Details
- March 2014
- Editorial
Limits on Use of Health Economic Assessments for Rare Diseases
By: Hanna I. Hyry, Ariel Dora Stern, Jonathan CP Roos and Timothy M. Cox
Funding of expensive treatments for rare ('orphan') diseases is contentious. These agents fare poorly on 'efficiency' or health economic measures, such as the QALY, because of high cost and frequently poor gains in quality of life and survival. We show that...
View Details
Hyry, Hanna I., Ariel Dora Stern, Jonathan CP Roos, and Timothy M. Cox. "Limits on Use of Health Economic Assessments for Rare Diseases." hcu016. QJM: An International Journal of Medicine 107, no. 3 (March 2014): 241–245.
- Article
The Aravind Eye Care System: Making Sight Affordable
By: V. Kasturi Rangan and R. D. Thulasiraj
Keywords:
Health Care and Treatment
Rangan, V. Kasturi, and R. D. Thulasiraj. "The Aravind Eye Care System: Making Sight Affordable." Innovations: Technology, Governance, Globalization 2, no. 4 (Fall 2007): 35–52.
- October 2017
- Article
Progress In Interoperability: Measuring US Hospitals' Engagement In Sharing Patient Data
By: A Jay Holmgren, Vaishali Patel and Julia Adler-Milstein
Achieving an interoperable health care system remains a top US policy priority. Despite substantial efforts to encourage interoperability, the first set of national data in 2014 suggested that hospitals’ engagement levels were low. With 2015 data now available, we...
View Details
Keywords:
Health;
Technology;
Electronic Health Records;
Health Care and Treatment;
Data and Data Sets;
Technology Networks;
Policy;
United States
Holmgren, A Jay, Vaishali Patel, and Julia Adler-Milstein. "Progress In Interoperability: Measuring US Hospitals' Engagement In Sharing Patient Data." Health Affairs 36, no. 10 (October 2017): 1820–1827.
- February 1996 (Revised April 2004)
- Case
Eli Lilly and Company: Innovation in Diabetes Care
By: Clayton M. Christensen
Summarizes Eli Lilly's history of innovation in its business, describing how the dimensions along which innovations have been made in the industry have changed. Lilly's innovation strategy has been to pursue ever higher performance products, while others in the...
View Details
Keywords:
Change;
Product;
Service Delivery;
Product Development;
Innovation and Management;
Innovation Strategy;
Health Care and Treatment;
Pharmaceutical Industry
Christensen, Clayton M. "Eli Lilly and Company: Innovation in Diabetes Care." Harvard Business School Case 696-077, February 1996. (Revised April 2004.)
- 29 Aug 2016
- News
Health Insurers’ Pullback Threatens to Create Monopolies
- October–December 2005
- Article
Medicine's Service Challenge: Blending Custom and Standard Care
By: Richard Bohmer
Bohmer, Richard. "Medicine's Service Challenge: Blending Custom and Standard Care." Health Care Management Review 30, no. 4 (October–December 2005): 322–330.
- 01 May 2008
- News
Interview: Does Our Health System Deliver Value?
- 01 Jan 2008
- News
Value-based Health Care: The MD Anderson Experience
- July 2021 (Revised July 2022)
- Case
Brigham & Women's Hospital: Using Patient Reported Outcomes to Improve Breast Cancer Care
By: Robert S. Kaplan, Navraj S. Nagra and Syed S. Shehab
Dr. Andrea Pusic, breast cancer reconstruction surgeon, wants to extend outcomes measurement beyond traditional surgical metrics of infections, complications, and survival rates. The case describes her development of a new mobile phone app, which collects patients’...
View Details
Keywords:
Health Care and Treatment;
Outcome or Result;
Cost Management;
Activity Based Costing and Management;
Mobile and Wireless Technology;
Health Testing and Trials;
Surveys;
Health Industry;
Boston
Kaplan, Robert S., Navraj S. Nagra, and Syed S. Shehab. "Brigham & Women's Hospital: Using Patient Reported Outcomes to Improve Breast Cancer Care." Harvard Business School Case 122-010, July 2021. (Revised July 2022.)
- Article
Consumer-Driven Health Care: Freeing Providers to Innovate
Herzlinger, Regina E. "Consumer-Driven Health Care: Freeing Providers to Innovate." hfm (Healthcare Financial Management) 58, no. 3 (March 2004): 66–68.
- 01 Dec 2017
- News
2017 in Health Care: Telemedicine Has Arrived
help achieve better access to care and a lower cost of care. And employers are embracing telemedicine as a way to provide employees convenient health care at a lower cost for...
View Details
- September 2014
- Supplement
Pfizer and AstraZeneca: Marketing an Acquisition (B)
By: John A. Quelch and James Weber
This (B) case provides a brief description of the outcome of the (A) case.
View Details
Keywords:
Health Care Policy;
Pharmaceutical Sales;
Mergers And Acquisitions;
Marketing;
Pharmaceutical Industry;
United Kingdom;
United States
Quelch, John A., and James Weber. "Pfizer and AstraZeneca: Marketing an Acquisition (B)." Harvard Business School Supplement 515-008, September 2014.
- November 2021
- Article
Determining Variable Costs in the Acute Urolithiasis Cycle of Care Through Time-driven Activity-based Costing
By: Tyler R. McClintock, David F. Friedlander, Aiden Y. Feng, Mahek A. Shah, Daniel J. Pallin, Steven L. Chang, Angela M. Bader, Thomas W. Feeley, Robert S. Kaplan and George E. Haleblian
Objective. To characterize full cycle of care costs for managing an acute ureteral stone using time-driven activity-based costing.
Methods. We defined all phases of care for patients presenting with an acute ureteral stone and built an... View Details
Methods. We defined all phases of care for patients presenting with an acute ureteral stone and built an... View Details
Keywords:
Time-Driven Activity-Based Costing;
Health Care and Treatment;
Cost;
Activity Based Costing and Management
McClintock, Tyler R., David F. Friedlander, Aiden Y. Feng, Mahek A. Shah, Daniel J. Pallin, Steven L. Chang, Angela M. Bader, Thomas W. Feeley, Robert S. Kaplan, and George E. Haleblian. "Determining Variable Costs in the Acute Urolithiasis Cycle of Care Through Time-driven Activity-based Costing." Urology 157 (November 2021): 107–113.